Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ortataxel in advanced renal cell carcinoma
NCT00044564Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ortataxel in renal cell carcinoma (RCC), sponsored by Bayer. Started Dec 2001; status: completed.
02
Drugs
ortataxel
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00044564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044564.